Lifestyle modification program (IM Healthy) for cancer survivors: Implementation of a reimbursable telehealth group program during the COVID-19 pandemic.

Publication date: Feb 06, 2025

We designed and pilot-tested a reimbursable lifestyle change program delivered via telehealth that was initiated during the COVID-19 pandemic. The program (IM Healthy) focused on increasing physical activity, improving nutrition, and facilitating stress management and healthy behavior change. Retrospective chart review was used to collect data on IM Healthy participants from the period of Sept 2021 to Aug 2022. The program was offered three days each week with the same topic presented each day. Patients chose which day they attended. Meetings were primarily led by a health psychologist, with intermittent weeks led by a dietitian or physical therapist. Chart review provided demographics, group attendance, ESAS-FS, PROMIS10, weight, and BMI. Patient feedback regarding the telehealth program was collected approximately 6 months following the data collection period. Patients (N = 50) mostly women (90%) with mean 57. 9 years old (SD = 11. 2) attended at least one group with an average of 13. 1 (SD = 10. 8; range = 1-45) attended sessions. Frequency of individual psychology sessions decreased after starting IM Healthy (z = - 2. 17, p = 0. 03). Overall, patients provided positive feedback including feelings of connectedness and physical and psychological benefit. Patients endorsed moderate to high perceived success in physical activity, nutrition, and stress management. We demonstrate that a reimbursable lifestyle change group program can be tailored to telehealth and is well-received and beneficial to cancer survivors.

Open Access PDF

Concepts Keywords
Nutrition Adult
Pandemic Aged
Pilot Cancer Survivors
Promis10 Cancer survivors
Therapist COVID-19
Diet
Exercise
Exercise
Female
Health Behavior
Humans
Integrative oncology
Life Style
Male
Middle Aged
Neoplasms
Pilot Projects
Retrospective Studies
Stress management
Stress, Psychological
Telehealth
Telemedicine

Semantics

Type Source Name
disease MESH Lifestyle
disease MESH cancer
disease MESH COVID-19 pandemic
drug DRUGBANK Spinosad
drug DRUGBANK Coenzyme M
disease MESH depressive disorders
drug DRUGBANK Aspartame
disease MESH psychological distress
disease MESH anxiety
disease IDO susceptibility
disease MESH sedentary lifestyle
disease MESH weight loss
disease MESH mental disorders
disease MESH depression
disease MESH recurrence
drug DRUGBANK Trestolone
disease IDO intervention
disease MESH eating disorders
disease MESH personality disorders
drug DRUGBANK Ranitidine
disease IDO symptom
disease MESH symptom burden
disease MESH clinical significance
disease MESH tics
disease MESH marital status
disease MESH overweight
disease MESH Sarcoma
disease MESH insomnia
disease MESH adjustment disorder
disease MESH anxiety disorder
drug DRUGBANK Tropicamide
drug DRUGBANK Water
disease MESH sleep quality
disease MESH retirement
disease IDO process
drug DRUGBANK Naproxen
disease MESH breast cancer
pathway KEGG Breast cancer
drug DRUGBANK Methyl isocyanate
drug DRUGBANK Esomeprazole
disease MESH Minimal clinically important difference
disease MESH Stress Psychological

Original Article

(Visited 1 times, 1 visits today)